Sharescart Research Club logo
Products
Research
Tools
About
ChatGPT Claude Perplexity
Summarize with
ChatGPT Claude Perplexity
Join Channel
Apollo Green₹ 72 (28.6%)ASK Investment₹ 895 (-3.2%)AVPL ₹ 49 (0%)Bootes Impex₹ 775 (-8.8%)CIAL ₹ 442 (-0.5%)CSK ₹ 254 (-3.1%)ESDS Software₹ 478 (2.8%)Garuda Aerospace₹ 468 (-2.1%)Goodluck Defence₹ 385 (16%)Hero Motors₹ 325 (0%)Hinduja Leyland₹ 248 (0%)ICL Fincorp₹ 25 (0%)Incred Holdings₹ 154 (2.7%)Kineco Limited₹ 3285 (0%)Lava ₹ 60 (15.4%)Market Simplified₹ 26 (-7.1%)Matrix Gas₹ 12 (-20%)Motilal Oswal₹ 12.25 (-2%)MSEI ₹ 6.35 (-2.3%)NCDEX ₹ 368 (-1.6%)NSE ₹ 1985 (-2%)Onix Renewable₹ 68 (21.4%)OYO ₹ 23 (-4.2%)OYO Assets₹ 9.25 (-7%)Philips India₹ 1250 (0%)Polymatech Electronics₹ 56 (-3.4%)SBI Mutual₹ 768 (-0.9%)Taparia Tools₹ 6050 (0%)VCI Chemical₹ 64 (0%)Zepto ₹ 40 (-4.8%)

15 Days Price Change

GPT Healthcare IPO

Closing In

  • days
  • Hours
  • Minutes
  • Seconds
Profile
Issue Size --
Profile
Price Range 177  to  186 per share
Profile
Min Investment ₹186
Profile
Lot Size 1
Profile
Face Value ₹10
Profile
Draft Prospectus --
Invest Before the IPO Goes Live

Buy unlisted shares early and participate in the growth before public listing.

Profile
  • Basic Info
  • IPO Tentative Timetable
  • IPO Lot Size
  • Subscription Status
  • Financials
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • Ratios
  • Growth Rates
  • Other info

Overview

GPT Healthcare Ltd is a cutting-edge healthcare technology company dedicated to revolutionizing patient care through innovative solutions. Specializing in artificial intelligence and data-driven healthcare applications, GPT Healthcare develops advanced tools to enhance diagnostics, treatment planning, and patient management. Their flagship product, HealthAssist AI, utilizes state-of-the-art algorithms to analyze medical data, improving accuracy in diagnosis and prognosis. Committed to fostering a seamless integration of technology into healthcare, GPT Healthcare aims to optimize medical workflows, reduce costs, and ultimately enhance patient outcomes. With a focus on research and development, the company strives to be at the forefront of healthcare innovation, driving positive change in the industry. Read More

Basic Info

Face Value 10 per share

Price 177  to  186 per share

P/E (x) 30.5

Sales( Cr.) 407

PAT( Cr.) 50

EPS 6.1

Draft Prospectus --

Exchange BSE-NSE

Promoter

Company Promoters

GPT Sons Private Limited Dwarika Prasad Tantia Dr. Om Tantia Shree Gopal Tantia

Pre Issue Share Holding 100%

Post Issue Share Holding 64.21%

Listing Details:

Listing Price: 216.15

Listing Gain: 13.95%

Current Price: 142.4

Gain On Issue: 142.4 | 0%

GMP: --

GMP %: -- %

IPO Tentative Timetable

Opening Date Feb 22, 2024
Closing Date Feb 26, 2024
Allotment Feb 27, 2024
Refund Feb 28, 2024
Delivery of Shares Feb 28, 2024
Listing Date Feb 29, 2024

IPO Lot Size

Application Lots Shares Amount
Retail (Min) 1 80 14,880
Retail (Max) 13 1040 193,440
S-HNI (Min) 14 1120 208,320
S-HNI (Max) 67 5360 996,960
B-HNI (Min) 68 5440 1,011,840

Objective of the Issue

1. Repayment or prepayment, in full or in part, of all or a portion of certain outstanding borrowings availed by the company from banks and financial institutions 2. General corporate purposes.

Issue

Category Nos Bid Bid (x)
QIB 14116662 244218253 17.3x
NII 4234998 46669678 11x
Retail 9881663 24111258 2.4x
EMP 0 0 0x
Total 28233323 240547912 8.5x

Net Sales (in cr.)

Total Income (in cr.)

Operating Profit (in cr.)

Net Profit (in cr.)

Shareholder Funds (in cr.)

Total Assets (in cr.)

GPT Healthcare Profit & Loss

#(Fig in Cr.) Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
Net Sales 146 172 212 243 337 361 400 407
Other Income 4 3 4 6 5 6 5 8
Total Income 150 175 216 249 342 367 405 416
Total Expenditure 120 136 176 194 264 287 312 324
Operating Profit 29 39 40 55 79 80 93 92
Interest 10 10 14 14 11 9 7 3
Depreciation 8 9 11 12 14 15 18 19
Exceptional Income / Expenses 0 0 0 0 0 0 0 0
Profit Before Tax 11 20 15 29 54 56 68 69
Provision for Tax 3 5 4 8 12 17 20 19
Profit After Tax 8 15 11 21 42 39 48 50
Adjustments 0 0 0 0 0 0 0 0
Profit After Adjustments 8 15 11 21 42 39 48 50
Adjusted Earnings Per Share 1.4 2.8 2 3.1 5.2 4.9 5.8 6.1

GPT Healthcare Balance Sheet

#(Fig in Cr.) Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Shareholder's Funds 101 116 127 134 158 165 218 248
Minority's Interest 0 0 0 0 0 0 0 0
Borrowings 48 69 96 102 72 40 4 6
Other Non-Current Liabilities 5 7 17 14 20 39 88 81
Total Current Liabilities 62 55 65 60 68 82 77 74
Total Liabilities 216 247 305 311 320 327 387 408
Fixed Assets 153 156 226 220 220 228 224 228
Other Non-Current Assets 30 44 16 5 14 18 83 102
Total Current Assets 33 47 63 86 86 81 80 79
Total Assets 216 247 305 311 320 327 387 408

GPT Healthcare Cash Flow

#(Fig in Cr.) Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Opening Cash & Cash Equivalents 0 0 1 0 5 8 7 2
Cash Flow from Operating Activities 22 32 41 43 66 66 69 67
Cash Flow from Investing Activities -6 -31 -54 -16 -5 5 -25 -33
Cash Flow from Financing Activities -16 0 12 -22 -57 -73 -49 -35
Net Cash Inflow / Outflow -0 1 -1 4 3 -2 -5 -0
Closing Cash & Cash Equivalent 0 1 0 5 8 7 2 2

GPT Healthcare Ratios

# Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Earnings Per Share (Rs) 1.41 2.79 2.04 3.14 5.21 4.88 5.82 6.08
CEPS(Rs) 2.97 4.38 4.09 6.24 6.91 6.75 8.01 8.4
DPS(Rs) 0 0 0.5 2 7 4 3.5 2.5
Book NAV/Share(Rs) 18.73 21.54 16.14 17.45 19.8 20.7 26.63 30.21
Core EBITDA Margin(%) 17.63 21.04 16.9 20.18 21.88 20.59 21.95 20.48
EBIT Margin(%) 14.34 17.83 13.67 17.56 19.33 18.04 18.78 17.89
Pre Tax Margin(%) 7.45 11.92 7 11.9 16.03 15.5 17 17.03
PAT Margin (%) 5.18 8.74 5.17 8.69 12.35 10.8 11.94 12.26
Cash Profit Margin (%) 10.94 13.71 10.4 13.83 16.38 14.93 16.43 16.94
ROA(%) 3.51 6.49 3.98 6.86 13.22 12.07 13.38 12.55
ROE(%) 7.52 13.87 10.81 23.34 33.05 24.11 24.89 21.41
ROCE(%) 11.78 16.07 13.04 17.14 25.56 26.93 32.61 29.6
Receivable days 30.53 24.72 24.42 25.99 16.6 17.24 20.5 19.72
Inventory Days 9.85 9.22 9.51 9.57 7.42 8.19 7.79 7.61
Payable days 317.72 276.41 266.36 187.63 114.49 149.93 155.71 167.11
PER(x) 0 0 0 0 0 0 30.31 24.11
Price/Book(x) 0 0 0 0 0 0 6.63 4.86
Dividend Yield(%) 0 0 0 0 0 0 1.98 1.7
EV/Net Sales(x) 0.65 0.6 0.81 0.72 0.49 0.38 3.63 2.98
EV/Core EBITDA(x) 3.22 2.65 4.28 3.19 2.12 1.7 15.58 13.2
Net Sales Growth(%) 0 17.53 23.26 14.59 39 7 10.85 1.72
EBIT Growth(%) 0 46.1 -5.51 47.24 53.02 -0.15 15.38 -3.1
PAT Growth(%) 0 98.17 -27.08 92.52 97.51 -6.37 22.46 4.51
EPS Growth(%) 0 98.18 -27.08 54.18 66.12 -6.37 19.25 4.51
Debt/Equity(x) 0.77 0.75 0.9 0.92 0.6 0.39 0.06 0.05
Current Ratio(x) 0.53 0.86 0.97 1.44 1.25 0.99 1.04 1.06
Quick Ratio(x) 0.47 0.78 0.87 1.33 1.15 0.89 0.93 0.94
Interest Cover(x) 2.08 3.02 2.05 3.1 5.85 7.11 10.58 20.98
Total Debt/Mcap(x) 0 0 0 0 0 0 0.01 0.01

Sihora Industries Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR 2% 6% 14% 0%
Operating Profit CAGR -1% 5% 18% 0%
PAT CAGR 4% 6% 35% 0%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR -7% NA% NA% NA%
ROE Average 21% 23% 25% 20%
ROCE Average 30% 30% 26% 22%

Company Contact Information

GPT Healthcare Ltd.

Gpt Centre, J C-25 Sector I I I Salt Lake

IPO Lead Manager(s)

GPT Healthcare Ltd.

JM Financial Ltd.

Registrar Info

GPT Healthcare Ltd.

Frequently Asked Questions

All You Need To Know About IPO

When you leave without vesting, generally unvested ESOPs are cancelled. Vested ESOPs usually can be exercised after you depart, often within 3 to 6 months, depending on the company's ESOP plan.

For companies listed on a stock exchange, you can sell the shares any time after you exercise the ESOP option and the shares are in your demat account. If the company is unlisted or otherwise a startup, you can only sell the shares if and when the company announces a buyback or has a process for secondary sales.

Whenever you exercised your options to hold shares, you entered into a market risk situation, and if the valuation of the company drops, so do the shares.

Yes. ESOPs are valuable to the employer in that the employer is able to retain the best talent, align employee interests with company goals, and preserve cash while rewarding performance.

Wealth Icon
Don’t Miss Out on Unlisted Shares

Open your account today and gain instant access to top unlisted shares and pre-IPO opportunities.

whatsapp

Error!